Pharmacoeconomic

Pharmacoeconomic

Community-acquired pneumonia (CAP) is a serious and widespread infection due to its high incidence, morbidity, mortality and increased healthcare costs. This study aimed at investigating antibiotic combination regimen containing fluoroquinolone (Group A) and antibiotic combination regimen not contai...

Full description

Bibliographic Details
Main Authors:	Weiam A. Harwan, Maggie M. Abbassi, May M. El-Attar, Samar F. Farid
Format:	Article
Language:	English
Published:	Faculty of Pharmacy, Cairo University 2014-06-01
Series:	Bulletin of Faculty of Pharmacy Cairo University
Subjects:	Pharmacoeconomics Lower respiratory tract infections Community-acquired pneumonia Antibiotic therapy ICU
Online Access:	http://www.sciencedirect.com/science/article/pii/S1110093114000131

Similar Items

AZITHROMYCIN: MODERN PLACE OF THE DRUG IN THERAPY OF LOWER RESPIRATORY TRACTS INFECTIONS
by: S. I. Sazhnova, et al.
Published: (2017-11-01)

Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial
by: Claudine A. Blum, et al.
Published: (2023-12-01)

PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial
by: Cécile Bessat, et al.
Published: (2024-01-01)

Antibiotic Prescribing for Lower Respiratory Tract Infections and Community-Acquired Pneumonia: An Italian Pediatric Emergency Department’s Real-Life Experience
by: Luca Pierantoni, et al.
Published: (2023-09-01)

Clinical and laboratory findings in the diagnosis of bacterial pneumonia in children.
by: M Don, et al.
Published: (2008-03-01)

Pediatricians’ Compliance to the Clinical Management Guidelines for Community-Acquired Pneumonia in Infants and Young Children in Pakistan
by: Sadia Shakeel, et al.
Published: (2021-06-01)

The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia
by: Phuong T. K. Nguyen, et al.
Published: (2023-02-01)

Exploring the microbial landscape: uncovering the pathogens associated with community-acquired pneumonia in hospitalized patients
by: Karin Hansen, et al.
Published: (2023-12-01)

Viral and bacterial lung infections in children: algorithms for diagnosis and therapy. A review
by: Alexander B. Malakhov, et al.
Published: (2023-08-01)

Concordance in pathogen identification at the upper and lower respiratory tract of children with severe pneumonia
by: Heping Wang, et al.
Published: (2023-03-01)

Antibiotic Guideline Adherence at the Emergency Department: A Descriptive Study from a Country with a Restrictive Antibiotic Policy
by: Mariana B. Cartuliares, et al.
Published: (2023-11-01)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01)

FASTCAP study on the management of hospitalized patients with community-acquired pneumonia: pharmacoeconomic analysis of the prospective phase
by: C. Lazzaro, et al.
Published: (2013-05-01)

Thrombocytosis in relation to severity of lower respiratory tract infection in children aged 2 months to 5 years
by: Begum R, et al.
Published: (2023-04-01)

Secondary Bloodstream Infection caused by Streptococcus pneumoniae Primary Source either from Respiratory Pneumonia or Pneumococcusuria: A Case Report
by: G Vaishnavadevi
Published: (2023-03-01)

PHARMACOECONOMIC ANALYSIS OF EFFICACY OF DIFFERENT MODES OF ANTIBIOTIC PROPHYLAXIS IN CHOLECYSTECTOMY
by: A. N. Poborskiy, et al.
Published: (2016-10-01)

Idarubicin versus Doxorubicin in Acute Myeloid Leukemia: A Parallel Randomized Trial with Pharmacoeconomic Analysis
by: Amany El Zeiny, et al.
Published: (2024-01-01)

The real life application of a procalcitonin-based algorithm to reduce antibiotic exposure in hospitalized patients with community acquired pneumonia: a proof of concept
by: Filippo Pieralli, et al.
Published: (2016-09-01)

Pneumonia in nursing home patients: is it time for a specific therapeutic strategy?
by: Gualberto Gussoni, et al.
Published: (2013-04-01)

Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain
by: Ana Dacosta Urbieta, et al.
Published: (2024-12-01)

Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections
by: Rachina S.А., et al.
Published: (2023-09-01)

PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study
by: Katia J. Bruxvoort, et al.
Published: (2023-10-01)

Vitamin D status of children with lower respiratory tract infections and its correlation with severity of pneumonia: A comparative study
by: Mohammed Mujtaba Qureshi, et al.
Published: (2022-12-01)

The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases
by: N Nigro, et al.
Published: (2011-10-01)

Guidelines and management of hospitalized patients with community-acquired pneumonia: the Italian experience of the FASTCAP study
by: I. Iori, et al.
Published: (2013-05-01)

Patterns of respiratory tract infections in children under 5 years of age in a low–middle-income country
by: Nehal M. El-Koofy, et al.
Published: (2022-11-01)

Pneumococcal colonization and coinfecting respiratory viruses in children under 5 years in Addis Ababa, Ethiopia: a prospective case–control study
by: Fiseha Wadilo Wada, et al.
Published: (2024-02-01)

Clinical and immunological characteristics of bacterial pneumonia associated with HIV infection coupled to drug addiction
by: L. V. Puzyreva, et al.
Published: (2020-11-01)

Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendations
by: Marco Mantero, et al.
Published: (2017-10-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

Short antibiotic courses in community-acquired pneumonia in adults: less is better
by: A. I. Sinopalnikov
Published: (2018-10-01)

PLACE OF RESPIRATORY FLUOROQUINOLONES IN THERAPY OF COMMUNITY ACQUIRED PNEUMONIA: FOCUS ON HIGH-DOSE LEVOFLOXACINE THERAPEUTIC REGIME
by: A. I. Sinopalnikov
Published: (2017-11-01)

Pharmacoeconomic analysis of classic and alternative eradication therapy regimens for Helicobacter pylori
by: A. M. Veliyev, et al.
Published: (2019-05-01)

Pharmacoeconomic assessment of urinary tract infections in infants born to mather with pathological pregnancy
by: O. A. Shulakova, et al.
Published: (2016-04-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

Efficacy of lung ultrasound and chest X-ray in children with cough and fast breathing to search a prognostic diagnostic approach to predict childhood pneumonia
by: Shaik Md Sajid Basha, et al.
Published: (2023-09-01)

Lower respiratory tract infections among newly diagnosed sleep apnea patients
by: Jaana Keto, et al.
Published: (2023-09-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)